| Antigen | 19-aa peptide from (Gene Accession #JC7695) human MCHR2 (1); Designation (#MHCR21-P, control/blocking peptide) conjugated to KLH; Epitope location~ C-terminal, Cytoplasmic domain |
| Form | Affinity purified IgG |
| Product Type | Primary Antibodies |
| SpCrossreactivity | Human MCHR21-P peptide sequence is 89% conserved in chimp, 84% in monkey MCHR2. Mouse and rat sequence are not yet available. No significant sequence homology of MCHR21-P is seen with other MCHR1 or other GPCR. Antibody crossreactivity in various species is not established. |
| SpeciesReactivity | Human |
| SugApplications | Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the |
| SugNegativeControl | Non-immune Rabbit IgG Cat# 20009-1 |
| SugPositiveControl | Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid |
| SugSecAntibodies | http://4adi.com/commerce/ccc2480-secondary-antibodies-rabbit.htm |